TXNRD1 and acute respiratory distress syndrome: Administration of the TXNRD1 inhibitor aurothioglucose (ATG) is protective in murine models of acute lung injury (ALI), and protection is associated with increases in GSH-dependent antioxidant defenses [7, 19].